In vitro interactions between primycin and different statins in their effects against some clinically important fungi

Ildikó Nyilasi1,2, Sándor Kocsubé1,2, Miklós Pesti3

  • 1Department of Microbiology, Faculty of Science and Informatics, University of Szeged, Közép Fasor 52, H-6726 Szeged, Hungary.

Insights

Primycin (PN) and certain statins show antifungal activity against opportunistic fungi. Combining primycin with fluvastatin, lovastatin, or simvastatin demonstrated synergistic effects, enhancing fungal growth inhibition.

Area of Science:

  • Mycology
  • Pharmacology
  • Infectious Diseases

Background:

  • Opportunistic fungal infections pose significant threats, especially to immunocompromised individuals.
  • Existing antifungal therapies face challenges like resistance and toxicity, necessitating novel treatment strategies.
  • Primycin (PN) and statins are compounds with potential, yet their combined antifungal efficacy requires thorough investigation.

Purpose of the Study:

  • To evaluate the in vitro antifungal activity of primycin (PN) and various statins against opportunistic pathogenic fungi.
  • To investigate the in vitro interactions between primycin and different statins to identify potential synergistic or additive effects.
  • To determine the impact of these combinations on reducing effective concentrations for fungal growth inhibition.

Main Methods:

  • In vitro antifungal activity was assessed using minimum inhibitory concentration (MIC) assays.
  • Standard chequerboard titration method was employed to evaluate drug-drug interactions.
  • Tested fungal pathogens included Candida albicans, Candida glabrata, Paecilomyces variotii, Aspergillus fumigatus, Aspergillus flavus, and Rhizopus oryzae.

Main Results:

  • Primycin (PN) demonstrated potent activity against Candida albicans and Candida glabrata, and moderate activity against Paecilomyces variotii.
  • Flustrin (FLV) and simvastatin (SIM) exhibited broad-spectrum antifungal activity, while atorvastatin, rosuvastatin, and lovastatin (LOV) showed limited effects; pravastatin was ineffective.
  • Combinations of PN with FLV, LOV, or SIM resulted in synergistic and additive effects, significantly reducing the required concentrations for complete fungal growth inhibition.

Conclusions:

  • Primycin (PN) and specific statins (FLV, SIM, LOV) possess in vitro antifungal properties against key opportunistic fungi.
  • The combination of primycin with fluvastatin, lovastatin, or simvastatin offers a promising strategy for enhanced antifungal therapy.
  • Synergistic interactions suggest potential for reduced drug dosages and improved treatment outcomes in managing fungal infections.

Related Concept Videos

Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...